BioSpace News Archive

BGL’s Healthcare & Life Sciences team served as the exclusive financial advisor to ACOS

National eating disorders awareness and mental health advocate, Kirsten Haglund, community relations specialist for Timberline Knolls Residential Treatment Center, offers advice on how to make real change in 2019

FUJIFILM Cellular Dynamics, Inc. (FCDI), a US subsidiary of FUJIFILM Corporation (President: Kenji Sukeno) and a leading global developer and manufacturer of human induced pluripotent stem (iPS) cell technologies, has announced an investment of about $21 million to open a new cGMP-compliant*1 production facility with the goal of industrializing iPS cell manufacturing for regenerative medicine therapies.

New Orders, Production, and Employment Growing

Acer acquires worldwide rights to clinical-stage NK3 receptor antagonist

Topline data from largest global, placebo-controlled study in second line biliary tract cancer expected in the second half of 2019

– Expands Patient Access to Andexxa, the First and Only Antidote for Reversal of the Factor Xa Inhibitors Rivaroxaban or Apixaban – – Full Commercial Launch to Begin January 2019

Brammer Bio (“Brammer”), a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies, announces recent leadership appointments to support the growth of the organization.

Bayer has earned top honors on PRWeek’s 2018 “Best Places to Work” list.

Launched November 2017, the Healthy Paws Rescue Race is a grant program that runs several times each year, supporting nonprofit organizations that help pets who desperately need medical care and forever homes.